AGI-5198

AGI-5198

Catalog Number:
L002369140APE
Mfr. No.:
APE-A4339
Price:
$273
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          AGI-5198 is a selective R132H-IDH1 inhibitor which is identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG). It is also induced the expression of zinc finger and BTB domain–containing protein 16 (ZBTB16), known as promyelocytic leukemia zinc finger (PLZF), a transcriptional repressor protein which is located on chromosome 11q23 and has been shown to promote glial differentiation in the central nervous system. AGI-5198 is also able to induce the expression of genes and cell markers associated with glial-specific differentiation in glioma cell, the expression of differentiation-associated genes, reduce H3K9 trimethylaytion, and cause tumor growth inhibition.

      • Properties
        • Alternative Name
          AGI5198, AGI 5198; N-cyclohexyl-2-(3-fluoro-N-[2-(2-methylimidazol-1-yl)acetyl]anilino)-2-(2-methylphenyl)acetamide
          CAS Number
          1355326-35-0
          Molecular Formula
          C27H31FN4O2
          Molecular Weight
          462.56
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          ≥23.15 mg/mL in DMSO; insoluble in H2O; ≥18.17 mg/mL in EtOH with gentle warming and ultrasonic
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Yamashita AS, da Costa Rosa M, et al."Demethylation and epigenetic modification with 5-Azacytidine reduces IDH1 mutant glioma growth in combination with Temozolomide." Neuro Oncol. 2018 Sep 3. PMID:30184215

    We Also Recommend

    Apixaban

    $233

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.